776-P: Potent Weight Loss and Favorable Glycemic Control Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Animal Models
Park, Sang Hyun, Kim, Yohan, Kim, Jung Kuk, Lee, Dahae, Park, Eunjin, Kim, Jeong A, Hong, Sunghee, Choi, Jaehyuk, Bae, Sungmin, Lee, Sang Hyun, Choi, In Young
Published in Diabetes (New York, N.Y.) (01.06.2024)
Published in Diabetes (New York, N.Y.) (01.06.2024)
Get full text
Journal Article
798-P: Potential Cardioprotective Effects of HM15275, a Novel, Long-Acting GLP-1/GIP/GCG Triple Agonist, in Animal Models of Hypertension
Lee, Seon Myeong, Kim, Jung Kuk, Park, Eunjin, Kang, Hye Reyeon, Kim, Jeong A, Kim, Yohan, Hong, Sunghee, Bae, Sungmin, Lee, Sang Hyun, Choi, In Young
Published in Diabetes (New York, N.Y.) (01.06.2024)
Published in Diabetes (New York, N.Y.) (01.06.2024)
Get full text
Journal Article
799-P: Nephroprotective Effects of a Novel Long-Acting GLP-1/GIP/GCG Triple Agonist, HM15275, in Preclinical Models of Acute and Chronic Kidney Diseases tv pat
Lee, Seon Myeong, Park, Eunjin, Kim, Jung Kuk, Kang, Hye Reyeon, Kim, Jeong A, Kim, Yohan, Hong, Sunghee, Bae, Sungmin, Lee, Sang Hyun, Choi, In Young
Published in Diabetes (New York, N.Y.) (01.06.2024)
Published in Diabetes (New York, N.Y.) (01.06.2024)
Get full text
Journal Article
655-P: Multitarget Engagement Effect of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Animal Model of NASH
KIM, JUNG KUK, LEE, JONG SUK, KWON, HYUNJOO, PARK, EUNJIN, LEE, JONGSOO, BAE, SUNGMIN, LEE, SANG HYUN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
1804-P: HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist, Exhibits Anti-inflammatory and Fibrotic Effects in AMLN/TAA–Induced Liver Inflammation and Fibrosis Mice
KIM, JUNG KUK, LEE, JONG SUK, PARK, EUNJIN, LEE, JONGSOO, BAE, SUNGMIN, KIM, DAEJIN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
1830-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice
CHOI, JAEHYUK, KIM, JUNG KUK, LEE, SEON MYEONG, KWON, HYUNJOO, LEE, JONGSOO, BAE, SUNGMIN, KIM, DAEJIN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
657-P: Potential Effect of a Novel Combination of GLP-1RA (efpeglenatide) and Long-Acting Glucagon Analog (HM15136) in Animal Models of Metabolic Disorders
LEE, JONG SUK, KIM, JUNG KUK, LEE, SEON MYEONG, CHOI, JAEHYUK, PARK, EUNJIN, KIM, DAEJIN, BAE, SUNGMIN, LEE, SANG HYUN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
656-P: Antifibrotic Potential of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Fibrosis
KIM, JUNG KUK, LEE, JONG SUK, LEE, SEON MYEONG, KWON, HYUNJOO, CHOI, JAEHYUK, PARK, EUNJIN, BAE, SUNGMIN, KIM, DAEJIN, KIM, YOUNG HOON, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2021)
Published in Diabetes (New York, N.Y.) (01.06.2021)
Get full text
Journal Article
754-P: Antifibrotic Potential of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of IPF
LEE, SEON MYEONG, KIM, JEONG A., LEE, JONG SUK, KIM, JUNG KUK, BAN, YOUNG-HWAN, LEE, JONGSOO, BAE, SUNGMIN, KIM, DAEJIN, LEE, SANG HYUN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
735-P: Direct Anti-Inflammatory and Antifibrotic Effects of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist, HM15211, in Thioacetamide-Induced Mouse Model of Liver Injury and Fibrosis
KIM, JUNG KUK, LEE, JONG SUK, KIM, YOHAN, LEE, SEON MYEONG, KWON, HYUNJOO, PARK, EUNJIN, CHOI, JAEHYUK, BAE, SUNGMIN, KIM, DAEJIN, LEE, SANG HYUN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
1926-P: Potent Weight Loss Mechanism of a Novel Long-Acting Glucagon Analog, HM15136, in Animal Models of Obesity
LEE, JONG SUK, LEE, SEON MYEONG, KIM, JUNG KUK, LEE, JONGSOO, LEE, SANG DON, BAE, SUNGMIN, KIM, DAEJIN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
1803-P: Antifibrotic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in BDL-Induced Liver Fibrosis Mice
KIM, JUNG KUK, LEE, JONG SUK, KWON, HYUNJOO, LEE, JONGSOO, KIM, DAEJIN, BAE, SUNGMIN, LEE, SANG HYUN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article
1925-P: Beneficial Effects of a Novel Long-Acting Glucagon Analog, HM15136, on Obesity and Obesity-Related Metabolic Disorders in Animal Models
LEE, JONG SUK, LEE, SEON MYEONG, CHOI, JAEHYUK, PARK, EUNJIN, LEE, JONGSOO, LEE, SANG DON, BAE, SUNGMIN, KIM, DAEJIN, CHOI, IN YOUNG
Published in Diabetes (New York, N.Y.) (01.06.2020)
Published in Diabetes (New York, N.Y.) (01.06.2020)
Get full text
Journal Article